The global Vaccine & Therapeutics industry has been one of the fastest-growing sectors for Novaris Search. With the rise of the pandemic, the need for Vaccines and Therapeutics has soared, presenting an efficient and effective way to protect billions of people worldwide.
Our experienced team of consultants, led by Director, Olivia Banks, provide executive search solutions to small, multinational, not-for-profit and PE backed vaccine and therapeutic biotechs. Supporting continued scientific advancements, commercial market launch and project management, we offer tailored executive search across all functions from mid-management to C-level.
For more information, please reach out to Olivia – olivia.banks@novarissearch.com
Bioinformatics and AI are rapidly growing industries. Bioinformatic tools and analysis allow for a deeper understanding across genetic and genomic data sets to advance scientific human research. The need for bioinformatics is growing daily and it is an essential part of advancements in research, treatments, and diagnosis across a number of human diseases.
AI provides a new technology that speeds up bioinformatic and data analysis through machine learning models to successfully perform human tasks of analysing data in a cost and time effective manner. The speed of AI coupled with the insights of Bioinformatics massively advances life science research and improves human life.
Our team is experienced across all verticals of Bioinformatic and Artificial intelligence including:
CROs and CDMOs play crucial roles in the drug development and manufacturing process, providing outsourced services such as clinical trials, research, development, and production of pharmaceuticals. We understand the need for outsourcing clinical trials and drug development is more prevalent now than ever.
The opportunity that researchers have to advance new treatments can aid the reduction of chronic diseases that are increasingly impacting individuals’ quality of life. We assist CROs and CDMOs in finding skilled individuals with expertise in various areas of drug development, clinical research, project management, quality assurance, regulatory compliance, and manufacturing. Additionally, we understand how important it is to keep up to trends with the latest market development, with the rise in digitalisation, we can see the evolution of clinical trials and new technology and support with growth of teams within these areas.
An industry expected to reach a value of $150bn by 2028, IVD shows no sign of slowing down.
We have built invaluable relationships across many of the In Vitro Diagnostic industries and pride ourselves in supporting the growth of highly innovative startups, along with market leading multinationals.
